RADIQAL Study (Radiation Dose and Image Quality Trial)

NCT06944509 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

824

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: treatment with the Azurion system with Xres5
OTHER: Azurion with Clairy IQ

Sponsor

Philips Clinical & Medical Affairs Global